Lung parenchymal calcifications in a child with cystic fibrosis

Heidi Lynch1, Frank Qian1, Matthew D Wong1,2,3

  • 1Department of Pediatric Respiratory and Sleep Medicine Queensland Children's Hospital South Brisbane Queensland Australia.

Insights

A 6-year-old girl with cystic fibrosis developed lung calcifications. Histopathology revealed dystrophic calcification within necrotic debris, indicating a severe disease manifestation.

Area of Science:

  • Pulmonology
  • Pediatric Medicine
  • Pathology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs.
  • Homozygous p.Phe508del mutation is the most common CF genotype, often leading to severe lung disease.
  • Bronchiectasis and obstructive lung disease are hallmark complications of advanced CF.

Observation:

  • A 6-year-old female patient with severe, multi-lobar bronchiectasis and obstructive lung disease due to cystic fibrosis was evaluated.
  • Computed tomography (CT) scan of the chest revealed significant parenchymal calcifications in the right middle lobe.
  • Lung biopsy of the calcified area was performed for histopathological examination.

Findings:

  • Histopathology demonstrated fibrous tissue with chronic inflammation.
  • Immune cell infiltration included CD3+ T-lymphocytes and macrophages.
  • No granulomas were observed, and dystrophic calcification was identified within necrotic debris.

Implications:

  • This case highlights an unusual manifestation of cystic fibrosis with parenchymal calcifications.
  • The findings suggest dystrophic calcification can occur in the context of chronic inflammation and necrosis in CF lung disease.
  • Further research may explore the mechanisms and clinical significance of calcifications in severe pediatric cystic fibrosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
382
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
307
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
230
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
139
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
40